Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,770.50
Bid: 1,770.50
Ask: 1,771.00
Change: 9.50 (0.54%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,772.50
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATING CHANGES: Four Brokers Cut Pearson Price Target

Fri, 24th Jan 2014 10:06

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
KEPLER CHEUVREUX STARTS BP WITH 'BUY' - PRICE TARGET 545 PENCE
----------
KEPLER CHEUVREUX STARTS BG GROUP WITH 'HOLD' - PRICE TARGET 1300 PENCE
----------
BERENBERG CUTS GLAXOSMITHKLINE TO 'HOLD' ('BUY') - PRICE TARGET 1750 (1790) PENCE
----------
CREDIT SUISSE CUTS WILLIAM HILL PRICE TARGET TO 445 (465) PENCE - UNDERPERFORM
----------
NOMURA CUTS PEARSON PRICE TARGET TO 1050 (1140) PENCE - 'REDUCE'
----------
EXANE BNP CUTS PEARSON PRICE TARGET TO 1400 (1550) PENCE - 'OUTPERFORM'
----------
MORGAN STANLEY CUTS PEARSON PRICE TARGET TO 1150 (1225) PENCE - 'UNDERWEIGHT'
----------
GOLDMAN CUTS PEARSON PRICE TARGET TO 1380 (1450) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES TUI TRAVEL PRICE TARGET TO 480 (410) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS COMPASS GROUP TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 1060 (950) P
----------
ORIEL CUTS COMPASS GROUP TO 'HOLD' ('BUY')
----------
JPMORGAN RAISES INTERCONTINENTAL HOTELS PRICE TARGET TO 2030 (1800) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES LSE PRICE TARGET TO 1622 (1539) PENCE - 'UNDERWEIGHT'
----------
UBS RAISES LONDON STOCK EXCHANGE PRICE TARGET TO 1830 (1680) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES WHITBREAD PRICE TARGET TO 4500 (3950) PENCE - 'OVERWEIGHT'
----------
EXANE BNP RAISES ADMIRAL GROUP PRICE TARGET TO 932 (903) P - UNDERPERFORM
----------
MORGAN STANLEY CUTS ABERDEEN TO UNDERWEIGHT (EQUAL-WEIGHT) - TARGET 393 (492) P
----------
MORGAN STANLEY CUTS TULLOW OIL PRICE TARGET TO 1175 (1510) PENCE - 'OVERWEIGHT'
----------
FTSE 250
----------
BERENBERG INITIATES DOMINO PRINTING WITH 'HOLD' - TARGET 860 PENCE
----------
DEUTSCHE BANK RAISES ST JAMES'S PLACE PRICE TARGET TO 810 (755) PENCE - 'BUY'
----------
GOLDMAN RAISES ST JAMES'S PLACE PRICE TARGET TO 840 (810) PENCE - 'BUY'
----------
NOMURA RAISES ST JAMES'S PLACE PRICE TARGET TO 845 (759) PENCE - 'BUY'
----------
CREDIT SUISSE CUTS LADBROKES PRICE TARGET TO 160 (170) PENCE - 'UNDERPERFORM'
----------
GOLDMAN CUTS DAIRY CREST TO 'CONV. SELL LIST' ('SELL') - TARGET 351 (404) P
----------
GOLDMAN CUTS EVRAZ PRICE TARGET TO 90 (110) PENCE - 'SELL'
----------
GOLDMAN CUTS FERREXPO PRICE TARGET TO 190 (200) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES POLYMETAL PRICE TARGET TO 420 (330) PENCE - 'SELL'
----------
JPMORGAN RAISES THOMAS COOK PRICE TARGET TO 230 (200) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES BETFAIR PRICE TARGET TO 990 (975) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES GREENE KING PRICE TARGET TO 960 (880) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES HELLERMANNTYTON PRICE TARGET TO 360 (335) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES MARSTONS PRICE TARGET TO 180 (160) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES MITCHELLS & BUTLERS PRICE TARGET TO 460 (400) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES PLAYTECH PRICE TARGET TO 900 (825) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES RESTAURANT GROUP PRICE TARGET TO 750 (665) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES SERCO PRICE TARGET TO 575 (523) PENCE - 'OVERWEIGHT'
----------
EXANE BNP RAISES DIRECT LINE PRICE TARGET TO 231 (213) PENCE - 'UNDERPERFORM'
----------
EXANE BNP CUTS ESURE GROUP TO UNDERPERFORM (NEUTRAL) - TARGET 264 (254) PENCE
----------
EXANE BNP INITIATES DEVRO WITH 'OUTPERFORM' - TARGET 370 PENCE
----------
MORGAN STANLEY CUTS ASHMORE PRICE TARGET TO 365 (410) PENCE - 'EQUAL-WEIGHT'
----------
MORGAN STANLEY RAISES AFREN PRICE TARGET TO 220 (210) PENCE - 'OVERWEIGHT'
----------
MORGAN STANLEY CUTS CAIRN ENERGY PRICE TARGET TO 350 (375) PENCE - 'OVERWEIGHT'
----------
MORGAN STANLEY CUTS OPHIR ENERGY PRICE TARGET TO 380 (465) PENCE - 'OVERWEIGHT'
----------
MORGAN STANLEY CUTS PREMIER OIL PRICE TARGET TO 350 (450) PENCE - EQUAL-WEIGHT
----------
MORGAN STANLEY CUTS SALAMANDER PRICE TARGET TO 130 (165) PENCE - 'EQUAL-WEIGHT'
----------
MORGAN STANLEY RAISES SOCO PRICE TARGET TO 410 (390) PENCE - 'UNDERWEIGHT'
----------
PANMURE RAISES PETRA DIAMONDS PRICE TARGET TO 144 (130) PENCE - 'BUY'
----------
NUMIS RAISES PETRA DIAMONDS PRICE TARGET TO 170 (165) PENCE - 'BUY'
----------
LIBERUM RAISES WORKSPACE GROUP PRICE TARGET TO 632 (584) PENCE - 'BUY'
----------
CANACCORD RAISES CLOSE BROTHERS TO 'BUY' ('HOLD') - TARGET 1500 (1430) PENCE
----------
NUMIS INCREASES CLOSE BROTHERS PRICE TARGET TO 1110 (1023) PENCE - 'REDUCE'
----------
ALL-SHARE AND AIM
----------
BERENBERG INITIATES TT ELECTRONICS WITH 'BUY' - TARGET 247 PENCE
----------
MORGAN STANLEY RAISES GENEL PRICE TARGET TO 1070 (1000) PENCE - 'EQUAL-WEIGHT'
----------
MORGAN STANLEY RAISES XCITE PRICE TARGET TO 180 (160) PENCE - 'OVERWEIGHT'
----------
MORGAN STANLEY CUTS FAROE PRICE TARGET TO 120 (130) PENCE - 'UNDERWEIGHT'
----------
PANMURE RAISES GOLDENPORT PRICE TARGET TO 70 (60) PENCE - 'BUY'
----------
GOLDMAN CUTS PETROPAVLOVSK PRICE TARGET TO 63 (64) PENCE - 'SELL'
----------
GOLDMAN CUTS POLYUS GOLD PRICE TARGET TO 190 (207) PENCE - 'NEUTRAL'
----------
CANACCORD RAISES CHARLES STANLEY GROUP PRICE TARGET TO 500 (450) PENCE - 'HOLD'
----------
NUMIS RAISES BROOKS MACDONALD PRICE TARGET TO 1570 (1560) PENCE - 'HOLD'
----------
GOLDMAN RAISES NEW WORLD RESOURCES PRICE TARGET TO 45,80 (44,40) PENCE - 'SELL'
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.